MYACUTECASE™ Mobile App
All the information you need for confident clinical decision- making with the VIDAS® Emergency & Critical Care assays.
Designed for healthcare professionals, MYACUTECASE™ is a first-of-its-kind app. Used in conjunction with clinical assessment and other laboratory findings, it provides comprehensive biomarker information and useful tools for:
Disclaimer: Product availability varies by country. Please consult your local bioMérieux representative for product availability in your country.
- Overview
- Assays
- Testimonials
- Resources
Overview
Based on your choice of pre-test probability scoring and/or validated clinical decision trees, MYACUTECASE™ aids in the result interpretation of the VIDAS® Emergency & Critical Care assays, automatically suggests and reminds you of the next steps in the diagnostic process and provides recommendations for treatment.
MYACUTECASE™ is an IVD product, based on international literature, guidelines and expert recommendations. It’s compliant with the intended use of the VIDAS® Emergency & Critical Care assays (VIDAS® B·R·A·H·M·S PCT™, VIDAS® D-Dimer Exclusion™ II, VIDAS® NT-proBNP2, VIDAS® High sensitive Troponin I).
- Rapid diagnosis: rule-out or rule-in of heart failure and acute myocardial infarction
- Early detection of sepsis, monitoring of patient response to therapy, and safe discontinuation of antibiotics
- Safe exclusion of suspected pulmonary embolism / deep vein thrombosis in patients with low/intermediate or unlikely pre-test probability
Available on
Intuitive and easy navigation
- Manage your case
- Obtain assay information
Decision-support tool
- Aid in result interpretation of VIDAS® assays using validated decision trees and test-specific cut-offs
- Patient management recommendations based on validated instructions for use for assays
Patient management tool
- Pre-test probability scoring
- Choice of different scoring systems
- On-demand storage of patient case
Patient Follow Up
- Notifications for follow-up testing / serial measurements
- Monitoring of PCT results for guided antibiotic therapy
Comprehensive high-value medical information on 4 key biomarkers in emergency and critical care settings: PCT, D-dimer, NT-proBNP, high-sensitivity cardiac troponin I
- Clinical utility
- International guidelines for use
- Expert recommendations
Assays
-
VIDAS® B•R•A•H•M•S PCT™
Important Biomarker for Improved Patient Management
Detects procalcitonin, a biomarker that aids in the risk assessment for progression to severe sepsis and septic shock. PCT also aids in decision making on antibiotic therapy for patients with lower respiratory tract infections (LRTI).
-
VIDAS® D-DIMER EXCLUSION™ II
Safe Exclusion of Venous Thromboembolism
VIDAS® D-Dimer Exclusion™ II is a highly-sensitive automated D-Dimer assay. Used in conjunction with assessment of clinical pretest probability, it allows safe exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE) in both low and intermediate suspected outpatient risk groups in just 20 minutes.
-
VIDAS® NT-proBNP2
Exclusion or Confirmation of Acute Heart Failure
VIDAS® NT-proBNP2 is a useful tool for rapid and clinical assessment and diagnosis of patients with symptoms of suspected heart failure.
High sensitivity and specificity allows initiation of timely, appropriate treatment.
Cost-effective tool adapted to emergency situations.
-
VIDAS® High sensitive Troponin I
Optimize the Management of Acute Coronary Syndrome (ACS)
The VIDAS® High sensitive Troponin I assay is intended to be used as an aid in the diagnosis of myocardial infarction delivering actionable results in only 2 hours and for the risk stratification of adult patients with acute coronary syndrome.
Testimonials
Experts feedbacks on their usage of MYACUTECASE™ app
Pr. Yann-Erick Claessens
Professor of Emergency Medicine, Monaco
Experts feedbacks on their usage of MYACUTECASE™ app
Dr. Eden A. Ferrer-Lasala
Emergency Medicine Physician Asian Hospital and Medical center
Resources
How do emergency physicians secure their decisions when they only have 7 minutes per patient?
In this first video, Professor Yann-Erick Claessens, Head of the Emergency Department at Princess Grace Hospital in Monaco, explains how D-dimer, procalcitonin (PCT), NT-proBNP and high-sensitivity cardiac troponin I are used to safely rule in or rule out a diagnostic hypothesis, support efficient triage and optimize patient care.
Procalcitonin (PCT) in the diagnosis and management of lower respiratory tract infection (LRTI)
Discover with Professor Yann-Erick Claessens, Head of the Emergency Department at Princess Grace Hospital in Monaco:
- How PCT informs clinicians on the likelihood of bacterial infection
- How PCT can be used to guide decisions on antibiotic therapy in order to decrease antibiotic consumption, improve patient outcomes and reduce hospital costs
- How using PCT to guide treatment decisions helps decrease the use of antibiotics and improve patient outcomes while reducing hospital costs
When pulmonary embolism (PE) is suspected, how does D-dimer help?
In this video, Professor Yann-Erick Claessens, Head of the Emergency Department at Princess Grace Hospital in Monaco, highlights the particular clinical value of D-Dimer as a safe and cost-effective exclusion test in patients with a low/intermediate or unlikely pre-test probability for PE.
High-sensitive cardiac Troponin I in acute myocardial infarction (AMI)
Professor Yann-Erick Claessens explains how High-sensitive cardiac Troponin I helps classify 70% of suspected acute myocardial infarction patients within 2 hours, decrease cardiac stress testing, discharge patients earlier from the ED and reduce global hospital costs.
How to use NT-proBNP to improve the diagnosis of acute heart failure
Professor Yann-Erick Claessens, Head of the Emergency Department at Princess Grace Hospital in Monaco, highlights the value of NT-proBNP in early identification of acute heart failure to improve patient outcomes and save hospital resources.
NT-proBNP in heart failure management
Are you an Emergency Physician?
Prof. Meune shows how NT-proBNP can be used in combination with echocardiography for diagnostic and prognostic purposes and to guide therapy. He also highlights the differences between NT-proBNP and BNP.
NT-proBNP in heart failure management
Are you a General Practitioner?
Prof. Meune shows how NT-proBNP can be used in combination with echocardiography for diagnostic and prognostic purposes and to guide therapy. He also highlights the differences between NT-proBNP and BNP.
NT-proBNP in heart failure management
Are you a Cardiologist?
Prof. Meune shows how NT-proBNP can be used in combination with echocardiography for diagnostic and prognostic purposes and to guide therapy. He also highlights the differences between NT-proBNP and BNP.
NT-proBNP in heart failure management
Are you a Biologist?
Prof. Meune shows how NT-proBNP can be used in combination with echocardiography for diagnostic and prognostic purposes and to guide therapy. He also highlights the differences between NT-proBNP and BNP.
- Container
- Container
